|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Peddareddigari V, Wang D and Dubois RN:
The tumor microenvironment in colorectal carcinogenesis. Cancer
Microenviron. 3:149–166. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hoesel B and Schmid JA: The complexity of
NF-κB signaling in inflammation and cancer. Mol Cancer. 12:862013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sakamoto K, Maeda S, Hikiba Y, Nakagawa H,
Hayakawa Y, Shibata W, Yanai A, Ogura K and Omata M: Constitutive
NF-kappaB activation in colorectal carcinoma plays a key role in
angiogenesis, promoting tumor growth. Clin Cancer Res.
15:2248–2258. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Puvvada SD, Funkhouser WK, Greene K, Deal
A, Chu H, Baldwin AS, Tepper JE and O'Neil BH: NF-kB and Bcl-3
activation are prognostic in metastatic colorectal cancer.
Oncology. 78:181–188. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lewander A, Gao J, Adell G, Zhang H and
Sun XF: Expression of NF-κB p65 phosphorylated at serine-536 in
rectal cancer with or without preoperative radiotherapy. Radiol
Oncol. 45:279–284. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Abdullah M, Rani AA, Sudoyo AW, Makmun D,
Handjari DR and Hernowo BS: Expression of NF-kB and COX2 in
colorectal cancer among native Indonesians: The role of
inflammation in colorectal carcinogenesis. Acta Med Indones.
45:187–192. 2013.PubMed/NCBI
|
|
8
|
Yu LL, Yu HG, Yu JP, Luo HS, Xu XM and Li
JH: Nuclear factor-kappaB p65 (RelA) transcription factor is
constitutively activated in human colorectal carcinoma tissue.
World J Gastroenterol. 10:3255–3260. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Patwardhan MB, Samsa GP, McCrory DC,
Fisher DA, Mantyh CR, Morse MA, Prosnitz RG, Cline KE and Gray RN:
Cancer care quality measures: Diagnosis and treatment of colorectal
cancer. Evid Rep Technol Assess (Full Rep). 1–116. 2006.PubMed/NCBI
|
|
10
|
Abdullah M, Sudoyo AW, Pranowo BS, Rini D,
Sutrisna B and Rani AA: Expression of NF-kappaB and COX-2 in young
versus older patients with sporadic colorectal cancer. Acta Med
Indones. 41:70–74. 2009.PubMed/NCBI
|
|
11
|
Balcerczak E, Pasz-Walczak G, Kumor P,
Panczyk M, Kordek R, Wierzbicki R and Mirowski M: Cyclin D1 protein
and CCND1 gene expression in colorectal cancer. Eur J Surg Oncol.
31:721–726. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Roelofs HM, Morsche Te RH, van Heumen BW,
Nagengast FM and Peters WH: Over-expression of COX-2 mRNA in
colorectal cancer. BMC Gastroenterol. 14:12014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Stanilov S, Drodeva Z and Stanilova S:
Higher TNF-alpha production detected in colorectal cancer patients
monocytes. Med Biotechnol. 26:107–110. 2011.
|
|
14
|
Rao CV, Janakiram NB and Mohammed A:
Lipoxygenase and cyclooxygenase pathways and colorectal cancer
prevention. Curr Colorectal Cancer Rep. 8:316–324. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yagihashi N, Kasajima H, Sugai S,
Matsumoto K, Ebina Y, Morita T, Murakami T and Yagihashi S:
Increased in situ expresión of nitric oxide synthase in human
colorectal cancer. Virchows Arch. 436:109–114. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zeestraten EC, Benard A, Reimers MS,
Schouten PC, Liefers GJ, van de Velde CJ and Kuppen PJ: The
prognostic value of the apoptosis pathway in colorectal cancer: A
review of the literature on biomarkers identified by
immunohistochemistry. Biomark Cancer. 5:13–29. 2013.PubMed/NCBI
|
|
17
|
Koskensalo S, Hagström J, Linder N, Lundin
M, Sorsa T, Louhimo J and Haglund C: Lack of MMP-9 expression is a
marker for poor prognosis in Dukes' B colorectal cancer. BMC Clin
Pathol. 12:242012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guba M, Seeliger H, Kleespies A, Jauch KW
and Bruns C: Vascular endothelial growth factor in colorectal
cancer. Int J Colorectal Dis. 19:510–517. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kojima M, Morisaki T, Sasaki N, Nakano K,
Mibu R, Tanaka M and Katano M: Increased nuclear factor-kB
activation in human colorectal carcinoma and its correlation with
tumor progression. Anticancer Res. 24:675–681. 2004.PubMed/NCBI
|
|
21
|
Yu HG, Yu LL, Yang Y, Luo HS, Yu JP, Meier
JJ, Schrader H, Bastian A, Schmidt WE and Schmitz F: Increased
expression of RelA/nuclear factor-kappa B protein correlates with
colorectal tumorigenesis. Oncology. 65:37–45. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sun SC, Ganchi PA, Béraud C, Ballar DW and
Greene WC: Autoregulation of the NF-kappa B transactivator RelA
(p65) by multiple cytoplasmic inhibitors containing ankyrin motifs.
Proc Natl Acad Sci USA. 91:1346–1350. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu D, Wu P, Zhao L, Huang L, Zhang Z, Zhao
S and Huang J: NF-kB expression and outcomes in solid tumors: A
systematic review and meta-analysis. Medicine (Baltimore).
94:e16872015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sutter T, Doi S, Carnevale KA, Arber N and
Weinstein IB: Expression of cyclins D1 and E in human colon
adenocarcinomas. J Med. 28:285–309. 1997.PubMed/NCBI
|
|
25
|
Antonacopoulou AG, Tsamandas AC, Petsas T,
Liava A, Scopa CD, Papavassiliou AG and Kalofonos HP: EGFR, HER-2
and COX-2 levels in colorectal cancer. Histopathology. 53:698–706.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cressey R, Pimpa S, Tontrong W,
Watananupong O and Leartprasertsuke N: Expression of
cyclooxygenase-2 in colorectal adenocarcinoma is associated with
p53 accumulation and hdm2 overexpression. Cancer Lett. 233:232–239.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Eberhart CE, Coffey RJ, Radhika A,
Giardiello FM, Ferrenbach S and DuBois RN: Up-regulation of
cyclooxygenase 2 gene expression in human colorectal adenomas and
adenocarcinomas. Gastroenterology. 107:1183–1188. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chu D, Zhao Z, Zhou Y, Li Y, Li J, Zheng
J, Zhao Q and Wang W: Matrix metalloproteinase-9 is associated with
relapse and prognosis of patients with colorectal cancer. Ann Surg
Oncol. 19:318–325. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Langers AM, Verspaget HW, Hawinkels LJ,
Kubben FJ, van Duijn W, van der Reijden JJ, Hardwick JC, Hommes DW
and Sier CF: MMP-2 and MMP-9 in normal mucosa are independently
associated with outcome of colorectal cancer patients. Br J Cancer.
106:1495–1498. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zeng ZS, Huang Y, Cohen AM and Guillem JG:
Prediction of colorectal cancer relapse and survival via tissue RNA
levels of matrix metalloproteinase-9. J Clin Oncol. 14:3133–3140.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sun N, Meng Q and Tian A: Expressions of
the anti-apoptotic genes Bag-1 and Bcl-2 in colon cancer and their
relationship. Am J Surg. 200:341–345. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Krajewska M, Moss SF, Krajewski S, Song K,
Holt PR and Reed JC: Elevated expression of Bcl-X and reduced Bak
in primary colorectal adenocarcinomas. Cancer Res. 56:2422–2427.
1996.PubMed/NCBI
|
|
33
|
Altomare DF, Rotelli MT, Pentimone A,
Rossiello MR, Martinelli E, Guglielmi A, De Fazio M, Marino F,
Memeo V, Colucci M and Semeraro N: Tissue factor and vascular
endothelial growth factor expression in colorectal cancer: Relation
with cancer recurrence. Colorectal Dis. 9:133–138. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cao D, Hou M, Guan YS, Jiang M, Yang Y and
Gou HF: Expression of HIF-1alpha and VEGF in colorectal cancer:
Association with clinical outcomes and prognostic implications. BMC
Cancer. 9:4322009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Grimm M, Lazariotou M, Kircher S,
Höfelmayr A, Germer CT, von Rahden BH, Waaga-Gasser AM and Gasser
M: Tumor necrosis factor-α is associated with positive lymph node
status in patients with recurrence of colorectal cancer indications
for anti-TNF-α agents in cancer treatment. Anal Cell Pathol (Amst).
33:151–163. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Soumaoro LT, Lida S, Uetake H, Ishiguro M,
Takagi Y, Higuchi T, Yasuno M, Enomoto M and Sugihara K: Expression
of 5-lipoxygenase in human colorectal cancer. World J
Gastroenterol. 12:6355–6360. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Moochhala S, Chhatwal VJ, Chan ST, Ngoi
SS, Chia YW and Rauff A: Nitric oxide synthase activity and
expression in human colorectal cancer. Carcinogenesis.
17:1171–1174. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kojima M, Morisaki T, Tsukahara Y,
Uchiyama A, Matsunari Y, Mibu R and Tanaka M: Nitric oxide synthase
expression and nitric oxide production in human colon carcinoma
tissue. J Surg Oncol. 70:222–229. 1999. View Article : Google Scholar : PubMed/NCBI
|
